HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EWG Seeks Court-Ordered Deadlines For FDA Action On Hazardous Hair Smoothers

This article was originally published in The Rose Sheet

Executive Summary

On the surface, FDA appears at this point to have answered EWG's 2011 petition seeking investigative and rulemaking action related to formaldehyde-releasing hair smoothers. It may be that EWG just doesn't like the answer and has run out of administrative and legal options, but the group is persisting with an amended complaint filed May 15 in federal court.

You may also be interested in...



NGOs’ Suit Against FDA Dismissed; No Standing In Formaldehyde Matter, Court Rules

“Injuries to an organization’s government lobbying and issue advocacy programs cannot be used to manufacture standing,” a D.C. district court judge asserts in his ruling against the Environmental Working Group and Women’s Voices for the Earth.

Former FDA Cosmetics Director Weighs In On Senator Hatch's Draft FCSMA

Under the draft FDA Cosmetic Safety and Modernization Act, a product could be deemed adulterated "regardless of whether it is known which particular substance or substances may render the cosmetic injurious." EAS Consulting Group's John Bailey offers his perspective on the provision and the overall bill in an exchange with the Rose Sheet.

FDA To Curtail Cosmetics Safety Work Under FY 2018 Budget Constraints

President Trump's budget proposal for fiscal 2018 calls for "targeted reductions to the Food Safety program, including reducing staff levels through attrition." In its justification to congressional appropriators, FDA says it will reduce funding for cosmetics safety work in order to focus on top priorities in the broad foods area.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS109261

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel